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ABSTRAK 
Analisis Mutasi Pasien Mental Retardasi dengan Epilepsi di Indonesia 
Afadiyanti A*, Yntema H**, Muttaqin Z*, Faradz SMH* 
 
Latar Belakang: Sebanyak 1-3% populasi umum menderita retardasi mental, 
25.5% diantaranya mengalami epilepsi. Fokus penelitian ini adalah pada pasien 
MR dengan epilepsi. Beberapa gen diketahui menjadi penyebab keduanya. Gen 
yang menjadi fokus pada penelitian ini adalah: SCN1A, ARX, STXBP1 dan LGI1. 
Ini adalah studi genetik pertama yang menyelidiki tentang MR dengan epilepsi 
pada populasi Indonesia. 
Tujuan: Mencari faktor genetik pada kasus MR dengan epilepsi di Indonesia.  
Material dan Metode: Sebanyak 32 kasus epilepsi didapat dari 527 pasien MR di 
SLB Semarang dan Bandung. Seluruh pasien MR telah diperiksa abnormalitas 
sitogenetiknya dan melalui skrining CGG repeats gen FMR1. Juga telah melewati 
skrining delesi/ duplikasi subtelomerik menggunakan MLPA. Satu kasus yang 
positif terdeteksi dieksklusi. Sebanyak empat kasus curiga sindromik diskrining 
gen-gen berikut: PTEN, UPF3B, MED12, UBE3A, dan TCF4. Kemudian seluruh 
kasus diperiksa mutasi gen SCN1A, LGI1 dan STXBP1. Skrining gen ARX 
dilakukan pada 19 pasien laki-laki.  
Hasil dan Diskusi: Tidak ditemukan mutasi pada skrining gen PTEN, MED12, 
UBE3A, maupun TCF4. Bbegitu juga pada gen ARX. Pada skrining gen SCN1A 
teridentifikasi 18 SNPs dan 2 UVs (c.2143+44C>T) dan c.2808G>A 
(p.Val936Val). Satu UV ditemukan pada gen STXBP1: c.730C>G (p.Leu244Val) 
namun tidak patogenik. Hasil tersebut mengindikasi bahwa variasi genomik pada 
gen terpilih untuk skrining bukan jenis yang umum ditemukan pada populasi MR 
dengan epilepsi di Indonesia. 
Kesimpulan: Tidak ditemukan mutasi patogenik pada pasien MR dengan epilepsi 
di Indonesia. Pentingnya konseling genetik utamanya untuk kalkulasi resiko 
penurunan, model penurunan dan manajemen pasien lebih lanjut. 
 
Kata kunci: retardasi mental, epilepsi, mutasi. 
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ABSTRACT 
Mutation Analysis of Mental Retardation Patients with Epilepsy in Indonesia 
Afadiyanti A*, Yntema H**, Muttaqin Z*, Faradz SMH* 
 
Background: About 1-3% of the general population has Mental Retardation, 
25.5% of them have epilepsy. This study focuses on patients with both MR and 
epilepsy. Several genes are known to be involved in MR with epilepsy. Only few 
of these genes have been analyzed for mutations in the Indonesian patient cohort: 
SCN1A, ARX, STXBP1 and LGI1. This is first genetic study for MR with epilepsy 
in Indonesian population. 
Aim: To seek underlying genetic defect in Indonesian MR patients with epilepsy.  
Materials and methods: Epilepsy cases were found in 32 out of 527 mentally 
retarded pupils at special-ed-schools in Semarang and Bandung. All 527 MR 
patients were previously screened for cytogenetic abnormalities and CGG repeats 
in the FMR1 gene. They were subsequently screened for subtelomeric 
deletions/duplications using MLPA analysis. From those 32 cases, one case with 
positive result was excluded. In four suspected syndromic patients specific genes 
(PTEN, UPF3B, MED12, UBE3A, and TCF4) were analyzed. Patients were 
screened for mutations in the SCN1A, ARX, LGI1 and STXBP1 genes.  
Results and Discussion: No mutation was found in the PTEN, MED12, UBE3A, 
or TCF4 genes. So did testing of 19 patients for ARX gene mutations. In the 
SCN1A gene, 18 SNPs and 2 UVs have been identified [(c.2143+44C>T) and 
(c.2808G>A) (p.Val936Val)]. One UV has been identified in the STXBP1 gene: 
(c.730C>G) (p.Leu244Val) but proven to be non pathogenic. These results 
suggest that genomic variations in screened genes are rarely found among MR 
with epilepsy population in Indonesia. 
Conclusions: No pathogenic mutation has been identified in Indonesian MR with 
epilepsy patients. Genetic councelling aspect is also very important to calculate 
the risk of inheritance, mode of inheritance and further management of the 
patients. 
 
Key words: mental retardation, epilepsy, mutation. 
* Centre of Biomedical Research Medical Faculty Diponegoro University 
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